Our extensive experience in Regenerative Medicine and Rejuvenating Therapies positions us at the forefront of research and innovation. Through continuous refinement of treatment protocols and a steadfast focus on results, we’ve cultivated unparalleled expertise and proprietary technology. This has enabled us to develop breakthrough solutions that redefine possibilities in: Regenerative Medicine, Disease Reversal, Rejuvenation and Wellness
These pioneering efforts are spearheaded under the Falcon Research and Innovation Council (FRIC) — a body dedicated to translating research into real-world healthcare advancements.
Regenerative Medicine
Harnessing advanced cellular therapies to repair and regenerate damaged tissues at their source.
Disease Reversal
Pioneering protocols aimed at halting and reversing the progression of chronic and degenerative conditions.
Rejuvenation and Wellness
Science-backed treatments that restore vitality, slow aging, and optimize overall well-being.
Leadership
"Our Aim is to use our Intellectual Property acquired from experience in Regenerative Medicine to develop New Formulations of products and New Technology to rewind the Biological Clock."
Former founder Director of Mauritius Institute of Biotechnology, Dr Zouberr Joomaye has been pivotal to the development and visibility of this sector in the Republic of Mauritius.
The President of the Council, Dr. Zouberr Joomaye, MD,
A French-trained Specialist in Internal Medicine
and Hepato-Gastroenterology
Dr Rattan Gujadhur,
Chemist and Biotech Executive
Dr Rattan Gujadhur is a Mauritian-born chemist and biotech executive recognized for his patented discovery of a soluble copper(I) catalyst during his PhD at the University of Massachusetts Amherst in 2003, leading to influential publications in organic catalysis.
He holds degrees in chemistry, including an MBA enhanced by coursework at Gilead/Golden Gate University and UCI Irvine focused on healthcare leadership
Research Focus
Our key areas of investigation include:
Aesthetic Medicine
Wellness
Stem-Cell Technology
Artificial Intelligence
Ethics and Clinical Governance
Independent Ethics Committee (IEC)
The Independent Ethics Committee (IEC) operates autonomously under the Falcon Healthcare Group and under the chairmanship of Dr Zouberr Joomaye has been a cornerstone of clinical research governance in Mauritius for over 12 years. It is the first and only private ethics body in the country recognized for reviewing and approving clinical research protocols with the highest integrity.
To date, the IEC has reviewed more than 200 research protocols — each cleared with a remarkable success rate — earning the trust of international Contract Research Organizations (CROs) such as Centre International de Développement Pharmaceutique, EUROFINS, and Cap Research.
Core Mandate
The IEC’s fundamental role is to protect the rights, safety, and well-being of research participants, ensuring all clinical trials are conducted in strict compliance with the Clinical Trials Act 2011 and globally recognized ethical standards.
Responsibilities of the IEC
- Review and approval of clinical research protocols, informed consent forms, and associated documentation before study initiation
- Ensuring research designs are ethically sound and participant risk is minimal and justified
- Verifying that participants are fully informed and have given voluntary consent
- Preserving independence from sponsors to uphold objective and unbiased ethical review
World-Class Care
Seamless Medical Care for Patients Away from Home.
Artemis Curepipe Hospital is committed to providing exceptional medical care to all those seeking treatment. Our International Patients Department goes the extra mile to ensure that patients feel comfortable throughout their stay and leave with restored health. With a comprehensive full-service office, we offer complete support to overseas patients seeking medical consultations, second opinions, or treatment.
We understand the challenges of receiving medical care in a foreign country, and our dedicated international patient coordinators provide unwavering support from pre-visit to post-visit stages. Our coordinators advocate for patients and assist with all aspects of their stay, streamlining assistance into four categories for efficient support.
Development and Commercialisation
All Intellectual Property and outcomes from our research programs are owned by Falcon Biologics Ltd (FBL), a wholly-owned subsidiary of the Falcon Healthcare Group. FBL specializes in the manufacturing and commercialisation of:
• Biologics
• Pharmaceuticals
• Nutraceuticals
• Food supplements
This seamless integration of research, ethics, and commercialisation underscores our mission: to advance medical science while delivering safe, effective, and innovative healthcare solutions.